Microneedle transdermal delivery of compound betamethasone in alopecia areata—A randomized controlled trial
Journal of the American Academy of Dermatology · 2025-02 · 92 (2) · 269-275
DOI: 10.1016/j.jaad.2024.09.059 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2025-02. Verfasst von Rui Qiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. Hauptthemen laut MEDLINE: Betamethasone, Alopecia Areata, Glucocorticoids. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Chinese Academy of Meteorological Sciences, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Alopecia areata (AA) places a considerable burden on patients. While intralesional glucocorticoid injection is an important therapy, it can cause severe pain. OBJECTIVE: To compare the efficacy and pain levels of microneedle transdermal delivery of compound betamethasone versus traditional intralesional injection in mild-to-moderate AA. METHODS: We conducted a randomized controlled trial in AA patients with a Severity of Alopecia Tool (SALT) score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. Electronic address: gypfeng@hotmail.com.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. Electronic address: ddlin@hotmail.com.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. Electronic address: yiqunjiang2017@163.com.
Förderung
- Chinese Academy of Meteorological Sciences
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Qiao, R., Zhu, J., Fang, J., Shi, H., Zhang, Z., Nie, J., Ge, Y., Lin, T., & Jiang, Y. (2025). Microneedle transdermal delivery of compound betamethasone in alopecia areata—A randomized controlled trial. Journal of the American Academy of Dermatology, 92(2), 269-275. https://doi.org/10.1016/j.jaad.2024.09.059
Vancouver
Qiao R, Zhu J, Fang J, Shi H, Zhang Z, Nie J, et al. Microneedle transdermal delivery of compound betamethasone in alopecia areata—A randomized controlled trial. Journal of the American Academy of Dermatology. 2025;92(2):269-275. doi:10.1016/j.jaad.2024.09.059
BibTeX
@article{Qiao2025,
author = {Qiao, Rui and Zhu, Jiaping and Fang, Jing and Shi, Hualing and Zhang, Ziye and Nie, Jin and Ge, Yiping and Lin, Tong and Jiang, Yiqun},
title = {Microneedle transdermal delivery of compound betamethasone in alopecia areata—A randomized controlled trial},
journal = {Journal of the American Academy of Dermatology},
year = {2025},
volume = {92},
number = {2},
pages = {269--275},
doi = {10.1016/j.jaad.2024.09.059}
}
EUVIMED